Log In
Print
BCIQ
Print
Print this Print this
 

MTL-007, NUC-1031

  Manage Alerts
Collapse Summary General Information
Company Morvus Technology Ltd.
DescriptionModified version of gemcitabine using ProTide technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner

NuCana BioMed Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today